Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 1/2019

13.04.2019 | Gynecologic Oncology

Prognostic factors and oncological outcomes of ovarian yolk sac tumors: a retrospective multicentric analysis of 99 cases

verfasst von: Gokhan Boyraz, Yasin Durmus, Irfan Cicin, Oguzhan Kuru, Esra Bostanci, Gunsu Kimyon Comert, Hanifi Sahin, Hulya Ayik, Isin Ureyen, Alper Karalok, Mehmet Mutlu Meydanli, Mehmet Coskun Salman, Nejat Ozgul, Anil Onan, Tayup Simsek, Kunter Yuce, Taner Turan

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the clinico-pathological prognostic factors and treatment outcomes in patients with ovarian yolk sac tumors (YST).

Methods

A multicenter, retrospective department database review was performed to identify patients with ovarian YST who underwent surgery between 2000 and 2017 at seven Gynecologic Oncology Centers in Turkey.

Results

The study group consisted of 99 consecutive patients with a mean age of 23.9 years. While 52 patients had early stage (stage I–II) disease, the remaining 47 patients had advanced stage (stage III–IV) disease. The uterus was preserved in 74 (74.8%) of the cases. The absence of gross residual disease following surgery was achieved in 76.8% of the cases. Of the 54 patients with lymph node dissection (LND), lymph node metastasis was detected in 10 (18.5%) patients. Of the 99 patients, only 3 patients did not receive adjuvant therapy, and most of the patients (91.9%) received BEP (bleomycin, etoposide, cisplatin) chemotherapy. Disease recurred in 21 (21.2%) patients. The 5-year disease-free survival (DFS) and overall survival (OS) in the entire cohort were 79.2% and 81.3%, respectively. In multivariate analysis, only residual disease following initial surgery was found to be significantly associated with DFS and OS in patients with ovarian YST (p = 0.026 and p = 0.001, respectively).

Conclusions

Our results demonstrate the significance of achieving no visible residual disease in patients with ovarian YST. Fertility-sparing approach for patients with no visible residual disease affected neither DFS nor OS. Although high lymphatic involvement rate was detected, the benefit of LND could not be demonstrated.
Literatur
2.
Zurück zum Zitat Tewari K, Cappuccini F, Disaia PJ, Berman ML, Manetta A, Kohler MF (2000) Malignant germ cell tumors of the ovary. Obstet Gynecol 95(1):128–133PubMed Tewari K, Cappuccini F, Disaia PJ, Berman ML, Manetta A, Kohler MF (2000) Malignant germ cell tumors of the ovary. Obstet Gynecol 95(1):128–133PubMed
3.
Zurück zum Zitat Smith HO, Berwick M, Verschraegen CF, Wiggins C, Lansing L, Muller CY et al (2006) Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol 107(5):1075–1085CrossRef Smith HO, Berwick M, Verschraegen CF, Wiggins C, Lansing L, Muller CY et al (2006) Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol 107(5):1075–1085CrossRef
4.
Zurück zum Zitat Fujita M, Inoue M, Tanizawa O, Minagawa J, Yamada T, Tani T (1993) Retrospective review of 41 patients with endodermal sinus tumor of the ovary. Int J Gynecol Cancer 3(5):329–335CrossRefPubMed Fujita M, Inoue M, Tanizawa O, Minagawa J, Yamada T, Tani T (1993) Retrospective review of 41 patients with endodermal sinus tumor of the ovary. Int J Gynecol Cancer 3(5):329–335CrossRefPubMed
5.
Zurück zum Zitat Kurman RJ, Norris HJ (1976) Endodermal sinus tumor of the ovary: a clinical and pathologic analysis of 71 cases. Cancer 38(6):2404–2419CrossRefPubMed Kurman RJ, Norris HJ (1976) Endodermal sinus tumor of the ovary: a clinical and pathologic analysis of 71 cases. Cancer 38(6):2404–2419CrossRefPubMed
6.
Zurück zum Zitat de la Motte Rouge T, Pautier P, Genestie C, Rey A, Gouy S, Leary A et al (2016) Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors. Gynecol Oncol 142(3):452–457CrossRef de la Motte Rouge T, Pautier P, Genestie C, Rey A, Gouy S, Leary A et al (2016) Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors. Gynecol Oncol 142(3):452–457CrossRef
7.
Zurück zum Zitat Dällenbach P, Bonnefoi H, Pelte MF, Vlastos G (2006) Yolk sac tumours of the ovary: an update. Eur J Surg Oncol 32(10):1063–1075CrossRefPubMed Dällenbach P, Bonnefoi H, Pelte MF, Vlastos G (2006) Yolk sac tumours of the ovary: an update. Eur J Surg Oncol 32(10):1063–1075CrossRefPubMed
8.
Zurück zum Zitat Lai CH, Chang TC, Hsueh S, Wu TI, Chao A, Chou HH et al (2005) Outcome and prognostic factors in ovarian germ cell malignancies. Gynecol Oncol 96(3):784–791CrossRefPubMed Lai CH, Chang TC, Hsueh S, Wu TI, Chao A, Chou HH et al (2005) Outcome and prognostic factors in ovarian germ cell malignancies. Gynecol Oncol 96(3):784–791CrossRefPubMed
9.
Zurück zum Zitat Murugaesu N, Schmid P, Dancey G, Agarwal R, Holden L, McNeish I et al (2006) Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment. J Clin Oncol 24(30):4862–4866CrossRefPubMed Murugaesu N, Schmid P, Dancey G, Agarwal R, Holden L, McNeish I et al (2006) Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment. J Clin Oncol 24(30):4862–4866CrossRefPubMed
10.
Zurück zum Zitat Nawa A, Obata N, Kikkawa F, Kawai M, Nagasaka T, Goto S et al (2001) Prognostic factors of patients with yolk sac tumors of the ovary. Am J Obstet Gynecol 184(6):1182–1188CrossRefPubMed Nawa A, Obata N, Kikkawa F, Kawai M, Nagasaka T, Goto S et al (2001) Prognostic factors of patients with yolk sac tumors of the ovary. Am J Obstet Gynecol 184(6):1182–1188CrossRefPubMed
11.
Zurück zum Zitat Kawai M, Kano T, Furuhashi Y, Mizuno K, Nakashima N, Hattori SE et al (1991) Prognostic factors in yolk sac tumors of the ovary. A clinicopathologic analysis of 29 cases. Cancer 67(1):184–192CrossRefPubMed Kawai M, Kano T, Furuhashi Y, Mizuno K, Nakashima N, Hattori SE et al (1991) Prognostic factors in yolk sac tumors of the ovary. A clinicopathologic analysis of 29 cases. Cancer 67(1):184–192CrossRefPubMed
12.
Zurück zum Zitat Cicin I, Saip P, Guney N, Eralp Y, Ayan I, Kebudi R et al (2009) Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors. Eur J Obstet Gynecol Reprod Biol 146(2):210–214CrossRefPubMed Cicin I, Saip P, Guney N, Eralp Y, Ayan I, Kebudi R et al (2009) Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors. Eur J Obstet Gynecol Reprod Biol 146(2):210–214CrossRefPubMed
13.
Zurück zum Zitat Nasioudis D, Chapman-Davis E, Frey MK, Caputo TA, Holcomb K (2017) Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base. Gynecol Oncol 147(2):296–301CrossRefPubMed Nasioudis D, Chapman-Davis E, Frey MK, Caputo TA, Holcomb K (2017) Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base. Gynecol Oncol 147(2):296–301CrossRefPubMed
14.
Zurück zum Zitat Mitchell PL, Al-Nasiri N, A’Hern R, Fisher C, Horwich A, Pinkerton CR (1999) Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases. Cancer 85(10):2232–2244CrossRefPubMed Mitchell PL, Al-Nasiri N, A’Hern R, Fisher C, Horwich A, Pinkerton CR (1999) Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases. Cancer 85(10):2232–2244CrossRefPubMed
15.
Zurück zum Zitat Gershenson DM, Miller AM, Champion VL, Monahan PO, Zhao Q, Cella D et al (2007) Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study. J Clin Oncol 25(19):2792–2797CrossRefPubMed Gershenson DM, Miller AM, Champion VL, Monahan PO, Zhao Q, Cella D et al (2007) Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study. J Clin Oncol 25(19):2792–2797CrossRefPubMed
16.
Zurück zum Zitat Ayhan A, Taskiran C, Bozdag G, Altinbas S, Altinbas A, Yuce K et al (2005) Endodermal sinus tumor of the ovary: the Hacettepe University experience. Eur J Obstet Gynecol Reprod Biol 123(2):230–234CrossRefPubMed Ayhan A, Taskiran C, Bozdag G, Altinbas S, Altinbas A, Yuce K et al (2005) Endodermal sinus tumor of the ovary: the Hacettepe University experience. Eur J Obstet Gynecol Reprod Biol 123(2):230–234CrossRefPubMed
17.
Zurück zum Zitat Mahdi H, Swensen RE, Hanna R, Kumar S, Ali-Fehmi R, Semaan A et al (2011) Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary. Br J Cancer 105(4):493–497CrossRefPubMedPubMedCentral Mahdi H, Swensen RE, Hanna R, Kumar S, Ali-Fehmi R, Semaan A et al (2011) Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary. Br J Cancer 105(4):493–497CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat de La Motte Rouge T, Pautier P, Rey A, Duvillard P, Kerbrat P, Troalen F et al (2011) Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 cases. Eur J Cancer 47(2):175–182CrossRef de La Motte Rouge T, Pautier P, Rey A, Duvillard P, Kerbrat P, Troalen F et al (2011) Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 cases. Eur J Cancer 47(2):175–182CrossRef
19.
Zurück zum Zitat Wang X, Ma Z, Li Y (2016) Ovarian yolk sac tumor: the experience of a regional cancer center. Int J Gynecol Cancer 26(5):884–891CrossRefPubMed Wang X, Ma Z, Li Y (2016) Ovarian yolk sac tumor: the experience of a regional cancer center. Int J Gynecol Cancer 26(5):884–891CrossRefPubMed
20.
Zurück zum Zitat Morgan RJ Jr, Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Behbakht K, Chen LM et al (2016) Ovarian cancer, version 1.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 14(9):1134–1163CrossRefPubMed Morgan RJ Jr, Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Behbakht K, Chen LM et al (2016) Ovarian cancer, version 1.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 14(9):1134–1163CrossRefPubMed
21.
Zurück zum Zitat Gershenson DM (1993) Update on malignant ovarian germ cell tumors. Cancer 71(4 Suppl):1581–1590CrossRefPubMed Gershenson DM (1993) Update on malignant ovarian germ cell tumors. Cancer 71(4 Suppl):1581–1590CrossRefPubMed
22.
Zurück zum Zitat Mangili G, Sigismondi C, Gadducci A, Cormio G, Scollo P, Tateo S et al (2011) Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study. Int J Gynecol Cancer 21(8):1414–1421CrossRefPubMed Mangili G, Sigismondi C, Gadducci A, Cormio G, Scollo P, Tateo S et al (2011) Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study. Int J Gynecol Cancer 21(8):1414–1421CrossRefPubMed
23.
Zurück zum Zitat Colombo N, Peiretti M, Garbi A, Carinelli S, Marini C, Sessa C (2012) Non-epithelial ovarian cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii20–vii26PubMed Colombo N, Peiretti M, Garbi A, Carinelli S, Marini C, Sessa C (2012) Non-epithelial ovarian cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii20–vii26PubMed
24.
Zurück zum Zitat Faure Conter C, Xia C, Gershenson D, Hurteau J, Covens A, Pashankar F et al (2018) Ovarian yolk sac tumors; does age matter? Int J Gynecol Cancer 28(1):77–84CrossRefPubMed Faure Conter C, Xia C, Gershenson D, Hurteau J, Covens A, Pashankar F et al (2018) Ovarian yolk sac tumors; does age matter? Int J Gynecol Cancer 28(1):77–84CrossRefPubMed
Metadaten
Titel
Prognostic factors and oncological outcomes of ovarian yolk sac tumors: a retrospective multicentric analysis of 99 cases
verfasst von
Gokhan Boyraz
Yasin Durmus
Irfan Cicin
Oguzhan Kuru
Esra Bostanci
Gunsu Kimyon Comert
Hanifi Sahin
Hulya Ayik
Isin Ureyen
Alper Karalok
Mehmet Mutlu Meydanli
Mehmet Coskun Salman
Nejat Ozgul
Anil Onan
Tayup Simsek
Kunter Yuce
Taner Turan
Publikationsdatum
13.04.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2019
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-019-05160-6

Weitere Artikel der Ausgabe 1/2019

Archives of Gynecology and Obstetrics 1/2019 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.